BCS Wealth Management’s AbbVie ABBV Stock Holding History

BCS Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$890K	Buy	3,535 +510	+17%	+$110K	0.16%	116
2026 Q1	$658K	Sell	3,025 -2,827	-48%	-$627K	0.13%	132
2025 Q4	$1.34M	Buy	5,852 +3,040	+108%	+$693K	0.14%	130
2025 Q3	$651K	Sell	2,812 -3,557	-56%	-$724K	0.15%	128
2025 Q2	$1.18M	Buy	6,369 +470	+8%	+$87.3K	0.25%	81
2025 Q1	$1.24M	Hold	5,899	–	–	0.32%	72
2024 Q4	$1.05M	Buy	5,899 +101	+2%	+$18.6K	0.26%	83
2024 Q3	$1.15M	Buy	5,798 +92	+2%	+$17.2K	0.49%	49
2024 Q2	$979K	Buy	5,706 +256	+5%	+$42.4K	0.48%	50
2024 Q1	$992K	Buy	5,450 +299	+6%	+$51.5K	0.32%	76
2023 Q4	$798K	Hold	5,151	–	–	0.29%	81
2023 Q3	$768K	Hold	5,151	–	–	0.32%	75
2023 Q2	$694K	Buy	+5,151	New	+$755K	0.51%	48
2023 Q1	–	Sell	-5,071	Closed	-$820K	–	160
2022 Q4	$820K	Sell	5,071 -15	-0.3%	-$2.3K	0.34%	76
2022 Q3	$683K	Hold	5,086	–	–	0.32%	80
2022 Q2	$779K	Hold	5,086	–	–	0.35%	69
2022 Q1	$824K	Sell	5,086 -26	-0.5%	-$3.78K	0.34%	70
2021 Q4	$692K	Buy	5,112 +26	+0.5%	+$3.07K	0.25%	87
2021 Q3	$549K	Hold	5,086	–	–	0.23%	88
2021 Q2	$573K	Sell	5,086 -2,151	-30%	-$242K	0.3%	71
2021 Q1	$783K	Hold	7,237	–	–	0.37%	59
2020 Q4	$775K	Hold	7,237	–	–	0.4%	57
2020 Q3	$634K	Sell	7,237 -128	-2%	-$12.1K	0.36%	57
2020 Q2	$723K	Buy	7,365 +664	+10%	+$58.5K	0.43%	50
2020 Q1	$511K	Buy	+6,701	New	+$571K	0.36%	56

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

BCS Wealth Management's ABBV Position: Q2 2026 in Review

BCS Wealth Management increased its AbbVie (ABBV) stake by 17% in Q2 2026, buying an estimated $110K and bringing the position to 3,535 shares worth $890K. The position accounts for 0.16% of the portfolio, ranked #116.

BCS Wealth Management first reported a position in ABBV in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.34M in Q4 2025. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

BCS Wealth Management held 3,535 shares of AbbVie worth $890K as of Q2 2026.
BCS Wealth Management bought 510 AbbVie shares in Q2 2026, an estimated $110K.
AbbVie made up 0.16% of BCS Wealth Management's portfolio in Q2 2026, its #116 holding.
BCS Wealth Management first reported a position in AbbVie in Q1 2020 and has held it in 25 quarters since.
BCS Wealth Management's AbbVie position peaked at $1.34M in Q4 2025.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on BCS Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.